Search Results - "Wrighton, Christopher J"

Refine Results
  1. 1

    Modification of vascular responses in xenotransplantation: Inflammation and apoptosis by Bach, Fritz H, Ferran, Christiane, Soares, Miguel, Wrighton, Christopher J, Anrather, Josef, Winkler, Hans, Robson, Simon C, Hancock, Wayne W

    Published in Nature medicine (01-09-1997)
    “…Interest in clinical xenotransplantation has increased markedly recently, despite a persisting debate regarding biochemical incompatibilities, risk of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Lipid-Heparin Infusion Suppresses the IL-10 Response to Trauma in Subcutaneous Adipose Tissue in Humans by Ikeoka, Dimas T., Pachler, Christoph, Mader, Julia K., Bock, Gerlies, Neves, Ana L., Svehlikova, Eva, Feichtner, Franz, Koehler, Gerd, Wrighton, Christopher J., Pieber, Thomas R., Ellmerer, Martin

    Published in Obesity (Silver Spring, Md.) (01-04-2011)
    “…An imbalance between pro‐ and anti‐inflammatory cytokine productions in adipose tissue is thought to contribute to chronic, systemic, low‐grade inflammation…”
    Get full text
    Journal Article
  4. 4

    Generation of Escherichia coli nitroreductase mutants conferring improved cell sensitization to the prodrug CB1954 by GROVE, Jane I, LOVERING, Andrew L, GUISE, Christopher, RACE, Paul R, WRIGHTON, Christopher J, WHITE, Scott A, HYDE, Eva I, SEARLE, Peter F

    Published in Cancer research (Chicago, Ill.) (01-09-2003)
    “…Escherichia coli nitroreductase (NTR) activates the prodrug CB1954 to a cytotoxic derivative, allowing selective sensitization of NTR-expressing cells or…”
    Get full text
    Journal Article
  5. 5

    Transcriptionally Targeted Nonviral Gene Transfer Using a β-Catenin/TCF-Dependent Promoter in a Series of Different Human Low Passage Colon Cancer Cells by Gaedtke, Lars, Pelisek, Jaroslav, Lipinski, Kai S, Wrighton, Christopher J, Wagner, Ernst

    Published in Molecular pharmaceutics (01-01-2007)
    “…Nonviral transfections of six low passage human colon cancer cell lines using the artificial β-catenin/TCF-dependent promoter CTP4 demonstrated a high promoter…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Optimization of a Synthetic β-Catenin-Dependent Promoter for Tumor-specific Cancer Gene Therapy by Lipinski, Kai S, Djeha, Hakim A, Gawn, Jonathan, Cliffe, Suzanne, Maitland, Norman J, Palmer, Daniel H, Mountain, Andrew, Irvine, Alistair S, Wrighton, Christopher J

    Published in Molecular therapy (01-07-2004)
    “…We recently published the construction and evaluation of a beta-catenin-dependent, highly active promoter, CTP1, and its possible application for the treatment…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Combined Adenovirus-Mediated Nitroreductase Gene Delivery and CB1954 Treatment: A Well-Tolerated Therapy for Established Solid Tumors by Djeha, A.Hakim, Thomson, T.Andrew, Leung, Hing, Searle, Peter F., Young, Lawrence S., Kerr, David J., Harris, Peter A., Mountain, Andrew, Wrighton, Christopher J.

    Published in Molecular therapy (01-02-2001)
    “…Gene-directed enzyme prodrug therapy (GDEPT) is a refinement of cancer chemotherapy that generates a potent cell-killing drug specifically in tumor cells by…”
    Get full text
    Journal Article
  10. 10

    Antitumor immune responses mediated by adenoviral GDEPT using nitroreductase CB1954 is enhanced by high-level coexpression of heat shock protein 70 by Djeha, Hakim A, Todryk, Stephen M, Pelech, Steven, Wrighton, Christopher J, Irvine, Alistair S, Mountain, Andrew, Lipinski, Kai S

    Published in Cancer gene therapy (01-06-2005)
    “…Gene-directed enzyme prodrug therapy (GDEPT) is a promising approach to local management of cancer through targeted chemotherapy. Killing localized tumors by…”
    Get full text
    Journal Article
  11. 11

    Structural and Mechanistic Studies of Escherichia coli Nitroreductase with the Antibiotic Nitrofurazone by Race, Paul R., Lovering, Andrew L., Green, Richard M., Ossor, Abdelmijd, White, Scott A., Searle, Peter F., Wrighton, Christopher J., Hyde, Eva I.

    Published in The Journal of biological chemistry (08-04-2005)
    “…The antibiotics nitrofurazone and nitrofurantoin are used in the treatment of genitourinary infections and as topical antibacterial agents. Their action is…”
    Get full text
    Journal Article
  12. 12

    Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954 by Djeha, A H, Hulme, A, Dexter, M T, Mountain, A, Young, L S, Searle, P F, Kerr, D J, Wrighton, C J

    Published in Cancer gene therapy (01-05-2000)
    “…Expression of the Escherichia coli enzyme nitroreductase (NTR) in mammalian cells enables them to activate the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide…”
    Get full text
    Journal Article
  13. 13
  14. 14

    A20 Inhibits NF-κB Activation in Endothelial Cells Without Sensitizing to Tumor Necrosis Factor–Mediated Apoptosis by Ferran, Christiane, Stroka, Deborah M., Badrichani, Anne Z., Cooper, Jeffrey T., Wrighton, Christopher J., Soares, Miguel, Grey, Shane T., Bach, Fritz H.

    Published in Blood (01-04-1998)
    “…Expression of the NF-κB–dependent gene A20 in endothelial cells (EC) inhibits tumor necrosis factor (TNF)–mediated apoptosis in the presence of cycloheximide…”
    Get full text
    Journal Article
  15. 15

    A20 Inhibits NF-κB Activation in Endothelial Cells Without Sensitizing to Tumor Necrosis Factor–Mediated Apoptosis by Ferran, Christiane, Stroka, Deborah M., Badrichani, Anne Z., Cooper, Jeffrey T., Wrighton, Christopher J., Soares, Miguel, Grey, Shane T., Bach, Fritz H.

    Published in Blood (01-04-1998)
    “…Expression of the NF-κB–dependent gene A20 in endothelial cells (EC) inhibits tumor necrosis factor (TNF)–mediated apoptosis in the presence of cycloheximide…”
    Get full text
    Journal Article
  16. 16

    Repressor titration: A novel system for selection and stable maintenance of recombinant plasmids by Williams, Steven G., Cranenburgh, Rocky M., Weiss, Amanda M.E., Wrighton, Christopher J., Hanak, Julian A.J., Sherratt, David J.

    Published in Nucleic acids research (01-05-1998)
    “…The propagation of recombinant plasmids in bacterial hosts, particularly in Escherichia coli, is essential for the amplification and manipulation of cloned DNA…”
    Get full text
    Journal Article
  17. 17

    Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector‐mediated expression of E. coli nitroreductase by Weedon, Sarah J., Green, Nicola K., McNeish, Iain A., Gilligan, Moira G., Mautner, Vivien, Wrighton, Christopher J., Mountain, Andrew, Young, Lawrence S., Kerr, David J., Searle, Peter F.

    Published in International journal of cancer (15-06-2000)
    “…The enzyme nitroreductase from E. coli can reduce the weak, monofunctional alkylating agent 5‐(aziridin‐1‐yl)‐2,4‐dinitrobenzamide (CB1954) to a potent…”
    Get full text
    Journal Article
  18. 18

    Optimization of a Synthetic [beta]-Catenin-Dependent Promoter for Tumor-specific Cancer Gene Therapy by Lipinski, Kai S, Djeha, Hakim A, Gawn, Jonathan, Cliffe, Suzanne, Maitland, Norman J, Palmer, Daniel H, Mountain, Andrew, Irvine, Alistair S, Wrighton, Christopher J

    Published in Molecular therapy (01-07-2004)
    “…We recently published the construction and evaluation of a β-catenin-dependent, highly active promoter, CTP1, and its possible application for the treatment of…”
    Get full text
    Journal Article
  19. 19

    High-Level, β-Catenin/TCF-Dependent Transgene Expression in Secondary Colorectal Cancer Tissue by Lipinski, Kai S., Djeha, A.Hakim, Ismail, Tariq, Mountain, Andrew, Young, Lawrence S., Wrighton, Christopher J.

    Published in Molecular therapy (01-10-2001)
    “…There is an urgent need for improved therapies for inoperable metastatic colon cancer. Genedirected enzyme prodrug therapy (GDEPT) using adenovirus vectors…”
    Get full text
    Journal Article
  20. 20

    High-Level, [beta]-Catenin/TCF-Dependent Transgene Expression in Secondary Colorectal Cancer Tissue by Lipinski, Kai S, Djeha, A Hakim, Ismail, Tariq, Mountain, Andrew, Young, Lawrence S, Wrighton, Christopher J

    Published in Molecular therapy (01-10-2001)
    “…There is an urgent need for improved therapies for inoperable metastatic colon cancer. Genedirected enzyme prodrug therapy (GDEPT) using adenovirus vectors…”
    Get full text
    Journal Article